Developing resources and animal models for studying high-threat biological agents.
Official title: Resources, Workforce Development, and Animal Models for the Rutgers RBL
Funded at Rutgers Biomedical and Health Sciences · NIH-10910194 · Data updated 2026-11-12
This study is all about making a special lab at Rutgers University even better at researching serious germs like the ones that cause COVID-19 and tuberculosis, so we can find new ways to treat and diagnose these diseases, which could help patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $4,189,403 |
| NIH project number | 5UC7AI180307-02 |
| Project ID | NIH-10910194 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals affected by or at risk for infections caused by high-threat pathogens like SARS-CoV-2 and tuberculosis.
✕Less likely to help
Patients with non-infectious diseases or those not affected by the targeted pathogens may not receive any benefit from this research.
What this research studies
This research focuses on enhancing the capabilities of the Rutgers University Regional Biocontainment Laboratory (RBL) to conduct advanced research on dangerous pathogens, including SARS-CoV-2 and Mycobacterium tuberculosis. The project aims to improve laboratory facilities and support services, establish best practices for working with high-containment pathogens, and develop animal models to better understand these diseases. By collaborating with academic and commercial partners, the RBL seeks to strengthen pandemic preparedness and biothreat response efforts. Patients may benefit indirectly through advancements in treatments and diagnostics for infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive measures for serious infectious diseases affecting patients.
How similar studies have gone: Previous research on similar high-threat pathogens has shown promise in improving treatment and understanding of infectious diseases, indicating that this approach is grounded in established scientific methods.
Where this research is happening
-
Rutgers Biomedical and Health Sciences
Newark, United States Active
Researchers
- Principal investigator: Alland, David — Rutgers Biomedical and Health Sciences
- Study coordinator: Alland, David
Related research
Other NIH-funded projects on the same topics.
-
Methylation and metabolism signals linked to lung function in kids with asthma
This grant looks at how genes, environment, and small chemical changes in the body together affect how lung function changes over time in children with asthma.
-
FEND-TB: Faster, better TB tests for all ages
A multi-institutional project aims to develop and validate faster TB diagnostic tools and drug-susceptibility tests so people of all ages, including children and those with extrapulmonary TB, can get quicker and more accurate results.
-
FEND-TB: Accelerating TB Diagnostics and Drug Susceptibility Testing
A multi‑institution collaboration will test new TB diagnostic tools and rapid drug-susceptibility tests to improve detection and treatment for people of all ages, including children and those with hard-to-diagnose TB.
-
Game-based mobile app to help pregnant women with overweight/obesity manage weight in Nepal
A new app designed for pregnant women in Nepal with overweight or obesity to help manage weight gain during pregnancy and reduce weight retention after birth.
-
Environmental factors and Lewy body dementia: linking claims data with lab work
Aims to find environmental factors that influence Lewy body dementia by combining big health data with lab studies, to understand what might worsen the condition and who is most at risk.
-
Identifying how ableism affects pregnancy and postpartum care for women with intellectual and developmental disabilities on Medicaid
This grant studies how bias and barriers in the healthcare system affect pregnancy and postpartum outcomes for women with intellectual and developmental disabilities who are on Medicaid and their babies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.